This statistic illustrates AstraZeneca's expenditure on research and development from 2006 to 2024. In 2024, AstraZeneca spent some 13.6 billion U.S. dollars on R&D. AstraZeneca plc is one of the top 10 pharmaceutical companies worldwide (based on Rx drug revenue). The multinational company is headquartered in London, UK. AstraZeneca is focused on products for the following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. Together with the Oxford University, the company also developed one of the first effective COVID-19 vaccines.
Research and development expenditure of AstraZeneca from 2006 to 2024
(in million U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
AstraZeneca, & U.S. Securities and Exchange Commission. (February 17, 2025). Research and development expenditure of AstraZeneca from 2006 to 2024 (in million U.S. dollars) [Graph]. In Statista. Retrieved May 04, 2025, from https://www.statista.com/statistics/266556/expenditure-on-research-and-development-of-astrazeneca-since-2006/
AstraZeneca, und U.S. Securities and Exchange Commission. "Research and development expenditure of AstraZeneca from 2006 to 2024 (in million U.S. dollars)." Chart. February 17, 2025. Statista. Accessed May 04, 2025. https://www.statista.com/statistics/266556/expenditure-on-research-and-development-of-astrazeneca-since-2006/
AstraZeneca, U.S. Securities and Exchange Commission. (2025). Research and development expenditure of AstraZeneca from 2006 to 2024 (in million U.S. dollars). Statista. Statista Inc.. Accessed: May 04, 2025. https://www.statista.com/statistics/266556/expenditure-on-research-and-development-of-astrazeneca-since-2006/
AstraZeneca, and U.S. Securities and Exchange Commission. "Research and Development Expenditure of Astrazeneca from 2006 to 2024 (in Million U.S. Dollars)." Statista, Statista Inc., 17 Feb 2025, https://www.statista.com/statistics/266556/expenditure-on-research-and-development-of-astrazeneca-since-2006/
AstraZeneca & U.S. Securities and Exchange Commission, Research and development expenditure of AstraZeneca from 2006 to 2024 (in million U.S. dollars) Statista, https://www.statista.com/statistics/266556/expenditure-on-research-and-development-of-astrazeneca-since-2006/ (last visited May 04, 2025)
Research and development expenditure of AstraZeneca from 2006 to 2024 (in million U.S. dollars) [Graph], AstraZeneca, & U.S. Securities and Exchange Commission, February 17, 2025. [Online]. Available: https://www.statista.com/statistics/266556/expenditure-on-research-and-development-of-astrazeneca-since-2006/
